Synta Pharmaceuticals Corp. (Nasdaq: SNTA) announced the entry into a Subscription Agreement with an entity affiliated with Bruce Kovner, one ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE